An Open-Label, Crossover Trial of Mirtazapine (15 and 30 mg) in Cancer Patients with Pain and Other Distressing Symptoms

Authors: Theobald D.E.; Kirsh K.L.; Holtsclaw E.; Donaghy K.; Passik S.D.

Source: Journal of Pain and Symptom Management, Volume 23, Number 5, May 2002 , pp. 442-447(6)

Publisher: Elsevier

Keywords: Mirtazapine; advanced cancer; pain; depression; symptoms; quality of life

Language: English

Document Type: Short communication

DOI: http://dx.doi.org/10.1016/S0885-3924(02)00381-0

Affiliations: 1: Oncology Symptom Control & Research, Community Cancer Care, , Indianapolis, IN, USA

Publication date: 2002-05-01

• In this: publication
• By this: publisher
• In this Subject: Pathology
• By this author: Theobald D.E. ;  Kirsh K.L. ;  Holtsclaw E. ;  Donaghy K. ;  Passik S.D.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers